Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
about
Latent transforming growth factor beta-binding protein-3 and fibulin-1C interact with the extracellular domain of the heparin-binding EGF-like growth factor precursorVascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residuesHomeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGFA single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cellsDirect identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase bindingMULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathwayGenomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoformVascular endothelial growth factor B, a novel growth factor for endothelial cellsInhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptorA novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesProteolytic processing regulates receptor specificity and activity of VEGF-C.Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisThe Emerging Regulation of VEGFR-2 in Triple-Negative Breast CancerCapture of endothelial cells under flow using immobilized vascular endothelial growth factorPharmacological aspects of Vipera xantina palestinae venomRole of targeted therapy in metastatic colorectal cancerThe vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelleDirect interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cellsMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cellsA heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factorVEGF gene therapy: therapeutic angiogenesis in the clinic and beyondVascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotypeVascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cellsIntrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epitheliumEffect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growthFlt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in miceMolecular mapping and functional characterization of the VEGF164 heparin-binding domainVascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryosEssential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in miceFetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endotheliumIdentification of distant drug off-targets by direct superposition of binding pocket surfacesTwo functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retinaDifferential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cellsFit for the Eye: Aptamers in Ocular DisordersNormalization of the vasculature for treatment of cancer and other diseases.Angiogenic growth factors in neural embryogenesis and neoplasia
P2860
04278742ab44282e15e0ef5204f6fa0a410823d414f76c94acfdbac2122216e0672695a6a342a72a249d61890d2c7b9f41ac8b41d061f12dede4625b36237c4b6facca17cc4404fa7615c45105e62ba159f94171f1758abbea1bfdf1155a818619bb28075e94b62c006b1b3f7c3c20513d4df207df356f016b9aead434982671124a5121c768d84d9ac17dbc96df97910edddb9c4bad86079b642e016abc69659a3e650ea686c40cc84d6febac3c13089a697d95d4b517336da4c35241caab70dbc377bb634b7689f1229fe729f26fa6bdef7740ac542351b31ca09f
P248
Q21284179-E97E87C3-7FE6-4AD8-8CBE-4DD81E5FA87CQ22008806-BD50151C-6913-4F9C-9923-80034484C132Q22253478-3A085436-D43A-4107-BDDA-94891C801274Q24291278-C8E8412D-F6BD-428A-AD1A-111A7BD00315Q24291582-99B52491-9858-4CC4-BE59-F605CC486822Q24294441-AA5F7195-DE5F-4549-9FE5-7A19A7C7198EQ24311517-276110DF-50E7-4660-A20F-1DA4725E9F66Q24312842-5F631482-C834-41C8-92D5-2393B8E10888Q24320710-51272A3F-7CF5-45F5-8C96-96DE54D0912FQ24336293-28E1C89D-2715-47A4-B1C2-40D354C6566DQ24532314-2FA5C8B8-548F-471E-A3D9-266457C54117Q24568018-BFAFDC02-2477-451B-B2F5-512C29FD3DBAQ24629523-45316259-6E2D-436C-9DC6-45F14F1218DCQ24684263-51A03CBF-D8BF-4083-A993-92D9A0A3A6DEQ26779248-D44313BA-D209-4594-B6E3-933C02319FF0Q26782026-8FF6DDAE-5A7F-4608-8D44-0DDEC4A5487EQ27005573-BD47FDF7-D181-45D2-977C-6FC4540418FEQ28068817-BA7DC093-53C7-4098-995E-550F3A8D41A7Q28205729-88669559-FF5D-4A2F-BB2A-61653AFDA3CBQ28210850-FF83A5C1-A3CD-4869-9281-A30136A2D68DQ28214421-4FF3C719-71B0-458F-8896-5E1B03A43BE2Q28240564-283EF405-CCF6-47BB-AE33-B060F1993CAFQ28251626-C0548963-3270-472A-A25E-D9274D862640Q28251810-EF3554B3-97A3-4C99-9C49-012B87C5DB72Q28260984-1370FC17-6D71-4C34-89B7-8C35D0AB2591Q28345309-77994F70-DB5B-4444-BAE0-F979FEE94930Q28345678-78A0B0EC-64EE-4DCA-B8BC-BB5DDE3EBB85Q28359761-0345DCDD-A57E-4F47-A6D7-25A6C2D82599Q28366604-EFAE89BD-B829-4263-AB2A-1BF2BF42FCD9Q28504776-C8D483FC-383C-4371-8057-C49C70F241ADQ28505465-679376CA-EF7E-4D0B-9329-5CB3D9EF57E1Q28506172-A3156E10-DFE5-471F-9096-EF388E300FD0Q28508807-8E47E69E-A9A4-489D-BEB5-8483014B5758Q28512027-0C679815-1E19-4FD6-AE6C-FF4CCC899A4AQ28538129-EE1BC04F-D320-4980-8F79-6E723E21949EQ28576658-34D8A712-B2DF-4550-901F-7AC4283992ADQ28582999-3BDA0FA2-E1A1-4F0A-9CF4-41AEF1D911B8Q28828283-50380E8F-959E-4B24-80F6-8127CCD5131EQ30471456-0B2A17D4-58FC-42CF-BE02-958392CA1AA9Q30498863-50596135-2D01-4F07-A1C7-BE1E7AA150DC
P2860
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Identification of the KDR tyro ...... endothelial cell growth factor
@ast
Identification of the KDR tyro ...... endothelial cell growth factor
@en
Identification of the KDR tyro ...... endothelial cell growth factor
@en-gb
Identification of the KDR tyro ...... endothelial cell growth factor
@nl
type
label
Identification of the KDR tyro ...... endothelial cell growth factor
@ast
Identification of the KDR tyro ...... endothelial cell growth factor
@en
Identification of the KDR tyro ...... endothelial cell growth factor
@en-gb
Identification of the KDR tyro ...... endothelial cell growth factor
@nl
prefLabel
Identification of the KDR tyro ...... endothelial cell growth factor
@ast
Identification of the KDR tyro ...... endothelial cell growth factor
@en
Identification of the KDR tyro ...... endothelial cell growth factor
@en-gb
Identification of the KDR tyro ...... endothelial cell growth factor
@nl
P2093
P921
P3181
P1476
Identification of the KDR tyro ...... endothelial cell growth factor
@en
P2093
B I Terman
D C Armellino
D Dimitrov
D Gospodarowicz
M Dougher-Vermazen
M E Carrion
P304
P3181
P356
10.1016/0006-291X(92)90483-2
P407
P577
1992-09-30T00:00:00Z